Solid Biosciences assumed with a Buy at Truist
positive
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
positive
What happened, with direct paths to the underlying reporting
Truist Financial initiated coverage on SLDB with a Buy rating and a $20 target. Current price shown as $9.10. Price has advanced 4.29 since the signal. Analyst: Danielle Brill.
Target: $20
Posted price: $9.1
Analyst firm: Truist Financial
Analyst: Danielle Brill
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.